Cutting-Edge Approaches to Smart Pharmaceutics and Vaccine Development
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 31 March 2026
Special Issue Editor
Interests: nanotechnology; antioxidant potential; nanofibers; niosomes; hydrogels; sponges; chitosan and hyaluronic wound dressings
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The development of smart pharmaceutics and next-generation vaccines is reshaping the future of modern medicine. This Special Issue, entitled “Cutting-Edge Approaches to Smart Pharmaceutics and Vaccine Development”, seeks to compile reviews and original research articles that explore the formulation together with the pharmaceutical application of advanced therapeutics, including immunization platforms. Emphasis will be placed on biomimetic approaches, smart delivery systems, and nanotechnology-driven innovations that improve immunogenicity and pharmacokinetic parameters and reduce the adverse effects associated with conventional pharmacotherapy, thus increasing compliance, adherence, and response to treatment. Furthermore, we encourage contributions that discuss the translational potential of mRNA and DNA vaccines and AI-assisted therapeutic/pharmaceutical discoveries. By providing a comprehensive overview of current progress that spans from fundamental science to clinical applications, this Special Issue aims to foster interdisciplinary dialogue and identify future directions in the vast domains of pharmacy and vaccinology/immunology.
Dr. Andreea-Teodora Iacob
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnology-driven innovations
- modern vaccines
- smart pharmaceutics
- AI-assisted pharmaceuticals
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
